Although many more investigations are needed, our data collectively suggest that intervention of WTAP, METTL3, METTL14, or an undetermined target of cell cycle-related molecules is a strategy for preventing and treating obesity or obesity-related diseases. This evidence concerns the gene METTL14 and obesity due to melanocortin 4 receptor deficiency.